Hong Kong medical research connected with global markets
Jifan Technology · Hong Kong

Take medical innovation
from Hong Kong
to the world

For biopharma, medical device and healthtech companies, we connect Hong Kong establishment, regulatory readiness, policy resources, research translation and global market development.

Since 2015Focused on healthcare and life sciences
Hong Kong HubConnecting policy, innovation parks, universities and clinical resources
End-to-End SupportFrom local setup to international growth
The Market-Entry Challenge

Global expansion is not a checklist.
It is a system of four connected challenges

01

Research Translation

Innovation must align with overseas regulation, clinical needs, product standards and commercial viability.

02

Regulatory Complexity

Registration, quality systems and healthcare promotion rules vary by market and continue to evolve.

03

Operating Complexity

Gaps in entity setup, people, tax, supply chain or cross-border structure compound cost and risk.

04

Market Access

Companies need credible positioning, local partnerships and sustainable routes into overseas markets.

Two-Layer Service Model

Build on a reliable foundation.
Scale through healthcare expertise

Business infrastructure and healthcare-specialist work advance together, reducing fragmented handoffs and duplicated effort.

FOUNDATION · BUSINESS INFRASTRUCTURE

Business Setup
& Operations

Establish the operating and compliance foundation required for long-term growth in Hong Kong and target markets.

  • Company, finance and tax
  • Policy and innovation parks
  • Talent and visas
  • Cross-border structure
  • Brand and channels
  • Supply-chain setup
SPECIALIST · HEALTHCARE CAPABILITIES

Healthcare
Specialist Support

Purpose-built support for regulated healthcare markets with long timelines and specialist requirements.

  • International access and registration support
  • Quality and research standards guidance
  • Medical language services
  • Industry–academic R&D collaboration
  • Clinical and academic collaboration
  • Medical cold chain and after-sales
Connected Service System

One pathway from establishment
to international growth

01 · POLICY & PARK

Innovation Policy & Parks

Map innovation policies and funding pathways, prepare applications and match facilities, talent and specialist resources to healthcare R&D needs.

02 · COMPLIANCE

Operations & Regulatory Readiness

Build the corporate, tax and legal foundation, with pathway support for product access, IP, technical files and quality systems.

03 · PEOPLE

Talent & Cross-Border Structure

Coordinate office selection, talent recruitment, work visas, ODI and cross-border employment planning.

04 · GROWTH

Brand, Channels & Digital Growth

Localise healthcare brands, develop compliant content, connect channels and distributors, operate events and deploy MarTech.

Cross-border medical cold-chain and logistics operations
05 · SUPPLY CHAIN

Healthcare Supply Chain

Support customs, sample delivery, medical cold chain, event logistics and overseas after-sales operations.

Hong Kong healthcare research and industry collaboration
06 · MEDICAL SPECIALIST

Medical, R&D & Clinical Collaboration

Connect medical language expertise, university–industry co-creation, clinical exchange and academic collaboration.

Transparent Delivery

Advance by phase.
Make every step verifiable

STEP 01

Diagnosis & Pathway Design

Assess the product, current qualifications, target markets and resources; then define priorities, milestones and risks.

STEP 02

Hong Kong Setup

Coordinate entity setup, policy, innovation parks, people, finance, tax and cross-border structure.

STEP 03

Healthcare Readiness & Market Access

Advance registration support, quality systems, IP, technical documentation and specialist language work.

STEP 04

Market Development & Growth

Combine brand, channels, academic collaboration, supply chain and digital capabilities into a sustainable international growth loop.

Anonymised Pathways

Turn a complex pathway
into practical progress

The following anonymised examples illustrate service pathways only. They do not promise any approval, timeline or commercial outcome.

Healthcare company research and collaboration team in Hong Kong
CASE 01 · MEDICAL DEVICE COMPANY

From a Hong Kong R&D base to export readiness

Local R&D team → innovation-park incubation → healthcare talent → cross-border supply chain → standards and qualification guidance.

Global healthcare product supply-chain operations
CASE 02 · INTEGRATED HEALTHCARE COMPANY

From product access to clinical brand trust

Local registration support → IP strategy → brand system → hospital and university collaboration → academic credibility.

About Jifan Technology

We understand healthcare.
And how companies go global

Jifan Technology grew from Jiyin Research Institute, founded in 2015. After a 2025 brand evolution and Hong Kong establishment, the team now focuses on compliance, market access, research translation and resource collaboration for healthcare companies.

2015Jiyin Research Institute is founded with a focus on healthcare and life sciences.
2025The organisation evolves into Jifan Technology and establishes in Hong Kong.
TodayConnect Hong Kong and international resources through an end-to-end healthcare market-entry service.
Jifan Technology healthcare research and market-entry collaboration
FAQ

Before you enter a market,
ask the right questions

This page provides general information and a basis for pathway discussions only. It is not legal, tax, regulatory or investment advice. Eligibility, timing and outcomes depend on company circumstances, current policy, regulator review and advice from licensed professionals.
Which healthcare companies does Jifan support?

We primarily support biopharma, medical device, diagnostics, medical imaging and related healthtech companies using Hong Kong as an international business hub.

Can we engage Jifan for one service only?

Yes. Services can be scoped by business stage, but we begin with an end-to-end pathway review so that a local decision does not conflict with later compliance or market objectives.

How are services delivered and accepted?

Work is delivered, reviewed and billed by phase. Deliverables, scope boundaries and third-party costs are documented in the project proposal.

How long does medical product registration take?

Timing depends on product classification, available technical files, target market and regulator feedback. After diagnosis, we provide assumption-based milestones rather than promising a fixed approval period.

How do we get started?

Share your product type, current qualifications, target market and expected timing. We will arrange an initial market-entry diagnosis.

Help the next healthcare innovation
reach the world from Hong Kong.

Tell us your product type, current qualifications and target market to receive an initial Hong Kong pathway and priority recommendation.

Book a Market-Entry Diagnosis